Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fa964f91cf2-trace').style.display = (document.getElementById('cakeErr67fa964f91cf2-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fa964f91cf2-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fa964f91cf2-code').style.display = (document.getElementById('cakeErr67fa964f91cf2-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fa964f91cf2-context').style.display = (document.getElementById('cakeErr67fa964f91cf2-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fa964f91cf2-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67fa964f91cf2-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 8889,
		&#039;title&#039; =&gt; &#039;UN hails studies showing antiretroviral drugs can prevent HIV infection&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;p&gt;
-The United Nations 
&lt;/p&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;div align=&quot;justify&quot;&gt;
The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.&lt;br /&gt;
&lt;br /&gt;
The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&amp;rdquo; said Michel Sidib&amp;eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &amp;ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&amp;rdquo; he added.&lt;br /&gt;
&lt;br /&gt;
One of the studies, conducted by the University of Washington&amp;rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &amp;ndash; in which one person had HIV infection and the other did not &amp;ndash; in Kenya and Uganda.&lt;br /&gt;
&lt;br /&gt;
The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.&lt;br /&gt;
&lt;br /&gt;
The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.&lt;br /&gt;
&lt;br /&gt;
The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.&lt;br /&gt;
&lt;br /&gt;
In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&amp;rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &amp;ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&amp;rdquo; she said.&lt;br /&gt;
&lt;br /&gt;
UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.&lt;br /&gt;
&lt;br /&gt;
It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.&lt;br /&gt;
&lt;br /&gt;
UNAIDS and WHO recommended that individuals and couples make &amp;ldquo;evidence-informed decisions&amp;rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.&lt;br /&gt;
&lt;br /&gt;
Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The United Nations, 13 July, 2011, http://www.un.org/apps/news/story.asp?NewsID=39023&amp;Cr=HIV/AIDS&amp;Cr1=&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 8991,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 8889,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | UN hails studies showing antiretroviral drugs can prevent HIV infection&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The United Nations 


&amp;nbsp;


The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;p&gt;-The United Nations &lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;div align=&quot;justify&quot;&gt;The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.&lt;br /&gt;&lt;br /&gt;The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&amp;rdquo; said Michel Sidib&amp;eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &amp;ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&amp;rdquo; he added.&lt;br /&gt;&lt;br /&gt;One of the studies, conducted by the University of Washington&amp;rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &amp;ndash; in which one person had HIV infection and the other did not &amp;ndash; in Kenya and Uganda.&lt;br /&gt;&lt;br /&gt;The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.&lt;br /&gt;&lt;br /&gt;The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.&lt;br /&gt;&lt;br /&gt;The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.&lt;br /&gt;&lt;br /&gt;In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&amp;rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &amp;ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&amp;rdquo; she said.&lt;br /&gt;&lt;br /&gt;UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.&lt;br /&gt;&lt;br /&gt;It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.&lt;br /&gt;&lt;br /&gt;UNAIDS and WHO recommended that individuals and couples make &amp;ldquo;evidence-informed decisions&amp;rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.&lt;br /&gt;&lt;br /&gt;Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 8889,
	&#039;title&#039; =&gt; &#039;UN hails studies showing antiretroviral drugs can prevent HIV infection&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;p&gt;
-The United Nations 
&lt;/p&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;div align=&quot;justify&quot;&gt;
The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.&lt;br /&gt;
&lt;br /&gt;
The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&amp;rdquo; said Michel Sidib&amp;eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &amp;ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&amp;rdquo; he added.&lt;br /&gt;
&lt;br /&gt;
One of the studies, conducted by the University of Washington&amp;rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &amp;ndash; in which one person had HIV infection and the other did not &amp;ndash; in Kenya and Uganda.&lt;br /&gt;
&lt;br /&gt;
The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.&lt;br /&gt;
&lt;br /&gt;
The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.&lt;br /&gt;
&lt;br /&gt;
The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.&lt;br /&gt;
&lt;br /&gt;
In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&amp;rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &amp;ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&amp;rdquo; she said.&lt;br /&gt;
&lt;br /&gt;
UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.&lt;br /&gt;
&lt;br /&gt;
It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.&lt;br /&gt;
&lt;br /&gt;
UNAIDS and WHO recommended that individuals and couples make &amp;ldquo;evidence-informed decisions&amp;rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.&lt;br /&gt;
&lt;br /&gt;
Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The United Nations, 13 July, 2011, http://www.un.org/apps/news/story.asp?NewsID=39023&amp;Cr=HIV/AIDS&amp;Cr1=&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 8991,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 8889
$metaTitle = &#039;LATEST NEWS UPDATES | UN hails studies showing antiretroviral drugs can prevent HIV infection&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
-The United Nations 


&amp;nbsp;


The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected...&#039;
$disp = &#039;&lt;p&gt;-The United Nations &lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;div align=&quot;justify&quot;&gt;The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.&lt;br /&gt;&lt;br /&gt;The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&amp;rdquo; said Michel Sidib&amp;eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &amp;ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&amp;rdquo; he added.&lt;br /&gt;&lt;br /&gt;One of the studies, conducted by the University of Washington&amp;rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &amp;ndash; in which one person had HIV infection and the other did not &amp;ndash; in Kenya and Uganda.&lt;br /&gt;&lt;br /&gt;The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.&lt;br /&gt;&lt;br /&gt;The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.&lt;br /&gt;&lt;br /&gt;The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.&lt;br /&gt;&lt;br /&gt;In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&amp;rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &amp;ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&amp;rdquo; she said.&lt;br /&gt;&lt;br /&gt;UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.&lt;br /&gt;&lt;br /&gt;It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.&lt;br /&gt;&lt;br /&gt;UNAIDS and WHO recommended that individuals and couples make &amp;ldquo;evidence-informed decisions&amp;rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.&lt;br /&gt;&lt;br /&gt;Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | UN hails studies showing antiretroviral drugs can prevent HIV infection | Im4change.org</title>
    <meta name="description" content="
-The United Nations 


&nbsp;


The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>UN hails studies showing antiretroviral drugs can prevent HIV infection</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <p>-The United Nations </p><p>&nbsp;</p><div align="justify">The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.<br /><br />The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.<br /><br />&ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&rdquo; said Michel Sidib&eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&rdquo; he added.<br /><br />One of the studies, conducted by the University of Washington&rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &ndash; in which one person had HIV infection and the other did not &ndash; in Kenya and Uganda.<br /><br />The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.<br /><br />The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.<br /><br />The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.<br /><br />In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.<br /><br />&ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&rdquo; she said.<br /><br />UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.<br /><br />It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.<br /><br />UNAIDS and WHO recommended that individuals and couples make &ldquo;evidence-informed decisions&rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.<br /><br />Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fa964f91cf2-trace').style.display = (document.getElementById('cakeErr67fa964f91cf2-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fa964f91cf2-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fa964f91cf2-code').style.display = (document.getElementById('cakeErr67fa964f91cf2-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fa964f91cf2-context').style.display = (document.getElementById('cakeErr67fa964f91cf2-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fa964f91cf2-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67fa964f91cf2-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 8889,
		&#039;title&#039; =&gt; &#039;UN hails studies showing antiretroviral drugs can prevent HIV infection&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;p&gt;
-The United Nations 
&lt;/p&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;div align=&quot;justify&quot;&gt;
The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.&lt;br /&gt;
&lt;br /&gt;
The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&amp;rdquo; said Michel Sidib&amp;eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &amp;ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&amp;rdquo; he added.&lt;br /&gt;
&lt;br /&gt;
One of the studies, conducted by the University of Washington&amp;rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &amp;ndash; in which one person had HIV infection and the other did not &amp;ndash; in Kenya and Uganda.&lt;br /&gt;
&lt;br /&gt;
The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.&lt;br /&gt;
&lt;br /&gt;
The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.&lt;br /&gt;
&lt;br /&gt;
The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.&lt;br /&gt;
&lt;br /&gt;
In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&amp;rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &amp;ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&amp;rdquo; she said.&lt;br /&gt;
&lt;br /&gt;
UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.&lt;br /&gt;
&lt;br /&gt;
It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.&lt;br /&gt;
&lt;br /&gt;
UNAIDS and WHO recommended that individuals and couples make &amp;ldquo;evidence-informed decisions&amp;rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.&lt;br /&gt;
&lt;br /&gt;
Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The United Nations, 13 July, 2011, http://www.un.org/apps/news/story.asp?NewsID=39023&amp;Cr=HIV/AIDS&amp;Cr1=&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 8991,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 8889,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | UN hails studies showing antiretroviral drugs can prevent HIV infection&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The United Nations 


&amp;nbsp;


The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;p&gt;-The United Nations &lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;div align=&quot;justify&quot;&gt;The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.&lt;br /&gt;&lt;br /&gt;The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&amp;rdquo; said Michel Sidib&amp;eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &amp;ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&amp;rdquo; he added.&lt;br /&gt;&lt;br /&gt;One of the studies, conducted by the University of Washington&amp;rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &amp;ndash; in which one person had HIV infection and the other did not &amp;ndash; in Kenya and Uganda.&lt;br /&gt;&lt;br /&gt;The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.&lt;br /&gt;&lt;br /&gt;The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.&lt;br /&gt;&lt;br /&gt;The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.&lt;br /&gt;&lt;br /&gt;In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&amp;rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &amp;ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&amp;rdquo; she said.&lt;br /&gt;&lt;br /&gt;UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.&lt;br /&gt;&lt;br /&gt;It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.&lt;br /&gt;&lt;br /&gt;UNAIDS and WHO recommended that individuals and couples make &amp;ldquo;evidence-informed decisions&amp;rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.&lt;br /&gt;&lt;br /&gt;Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 8889,
	&#039;title&#039; =&gt; &#039;UN hails studies showing antiretroviral drugs can prevent HIV infection&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;p&gt;
-The United Nations 
&lt;/p&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;div align=&quot;justify&quot;&gt;
The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.&lt;br /&gt;
&lt;br /&gt;
The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&amp;rdquo; said Michel Sidib&amp;eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &amp;ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&amp;rdquo; he added.&lt;br /&gt;
&lt;br /&gt;
One of the studies, conducted by the University of Washington&amp;rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &amp;ndash; in which one person had HIV infection and the other did not &amp;ndash; in Kenya and Uganda.&lt;br /&gt;
&lt;br /&gt;
The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.&lt;br /&gt;
&lt;br /&gt;
The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.&lt;br /&gt;
&lt;br /&gt;
The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.&lt;br /&gt;
&lt;br /&gt;
In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&amp;rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &amp;ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&amp;rdquo; she said.&lt;br /&gt;
&lt;br /&gt;
UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.&lt;br /&gt;
&lt;br /&gt;
It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.&lt;br /&gt;
&lt;br /&gt;
UNAIDS and WHO recommended that individuals and couples make &amp;ldquo;evidence-informed decisions&amp;rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.&lt;br /&gt;
&lt;br /&gt;
Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The United Nations, 13 July, 2011, http://www.un.org/apps/news/story.asp?NewsID=39023&amp;Cr=HIV/AIDS&amp;Cr1=&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 8991,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 8889
$metaTitle = &#039;LATEST NEWS UPDATES | UN hails studies showing antiretroviral drugs can prevent HIV infection&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
-The United Nations 


&amp;nbsp;


The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected...&#039;
$disp = &#039;&lt;p&gt;-The United Nations &lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;div align=&quot;justify&quot;&gt;The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.&lt;br /&gt;&lt;br /&gt;The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&amp;rdquo; said Michel Sidib&amp;eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &amp;ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&amp;rdquo; he added.&lt;br /&gt;&lt;br /&gt;One of the studies, conducted by the University of Washington&amp;rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &amp;ndash; in which one person had HIV infection and the other did not &amp;ndash; in Kenya and Uganda.&lt;br /&gt;&lt;br /&gt;The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.&lt;br /&gt;&lt;br /&gt;The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.&lt;br /&gt;&lt;br /&gt;The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.&lt;br /&gt;&lt;br /&gt;In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&amp;rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &amp;ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&amp;rdquo; she said.&lt;br /&gt;&lt;br /&gt;UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.&lt;br /&gt;&lt;br /&gt;It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.&lt;br /&gt;&lt;br /&gt;UNAIDS and WHO recommended that individuals and couples make &amp;ldquo;evidence-informed decisions&amp;rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.&lt;br /&gt;&lt;br /&gt;Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | UN hails studies showing antiretroviral drugs can prevent HIV infection | Im4change.org</title>
    <meta name="description" content="
-The United Nations 


&nbsp;


The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>UN hails studies showing antiretroviral drugs can prevent HIV infection</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <p>-The United Nations </p><p>&nbsp;</p><div align="justify">The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.<br /><br />The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.<br /><br />&ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&rdquo; said Michel Sidib&eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&rdquo; he added.<br /><br />One of the studies, conducted by the University of Washington&rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &ndash; in which one person had HIV infection and the other did not &ndash; in Kenya and Uganda.<br /><br />The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.<br /><br />The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.<br /><br />The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.<br /><br />In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.<br /><br />&ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&rdquo; she said.<br /><br />UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.<br /><br />It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.<br /><br />UNAIDS and WHO recommended that individuals and couples make &ldquo;evidence-informed decisions&rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.<br /><br />Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fa964f91cf2-trace').style.display = (document.getElementById('cakeErr67fa964f91cf2-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fa964f91cf2-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fa964f91cf2-code').style.display = (document.getElementById('cakeErr67fa964f91cf2-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fa964f91cf2-context').style.display = (document.getElementById('cakeErr67fa964f91cf2-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fa964f91cf2-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67fa964f91cf2-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 8889,
		&#039;title&#039; =&gt; &#039;UN hails studies showing antiretroviral drugs can prevent HIV infection&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;p&gt;
-The United Nations 
&lt;/p&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;div align=&quot;justify&quot;&gt;
The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.&lt;br /&gt;
&lt;br /&gt;
The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&amp;rdquo; said Michel Sidib&amp;eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &amp;ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&amp;rdquo; he added.&lt;br /&gt;
&lt;br /&gt;
One of the studies, conducted by the University of Washington&amp;rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &amp;ndash; in which one person had HIV infection and the other did not &amp;ndash; in Kenya and Uganda.&lt;br /&gt;
&lt;br /&gt;
The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.&lt;br /&gt;
&lt;br /&gt;
The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.&lt;br /&gt;
&lt;br /&gt;
The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.&lt;br /&gt;
&lt;br /&gt;
In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&amp;rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &amp;ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&amp;rdquo; she said.&lt;br /&gt;
&lt;br /&gt;
UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.&lt;br /&gt;
&lt;br /&gt;
It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.&lt;br /&gt;
&lt;br /&gt;
UNAIDS and WHO recommended that individuals and couples make &amp;ldquo;evidence-informed decisions&amp;rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.&lt;br /&gt;
&lt;br /&gt;
Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The United Nations, 13 July, 2011, http://www.un.org/apps/news/story.asp?NewsID=39023&amp;Cr=HIV/AIDS&amp;Cr1=&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 8991,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 8889,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | UN hails studies showing antiretroviral drugs can prevent HIV infection&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The United Nations 


&amp;nbsp;


The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;p&gt;-The United Nations &lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;div align=&quot;justify&quot;&gt;The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.&lt;br /&gt;&lt;br /&gt;The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&amp;rdquo; said Michel Sidib&amp;eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &amp;ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&amp;rdquo; he added.&lt;br /&gt;&lt;br /&gt;One of the studies, conducted by the University of Washington&amp;rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &amp;ndash; in which one person had HIV infection and the other did not &amp;ndash; in Kenya and Uganda.&lt;br /&gt;&lt;br /&gt;The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.&lt;br /&gt;&lt;br /&gt;The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.&lt;br /&gt;&lt;br /&gt;The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.&lt;br /&gt;&lt;br /&gt;In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&amp;rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &amp;ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&amp;rdquo; she said.&lt;br /&gt;&lt;br /&gt;UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.&lt;br /&gt;&lt;br /&gt;It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.&lt;br /&gt;&lt;br /&gt;UNAIDS and WHO recommended that individuals and couples make &amp;ldquo;evidence-informed decisions&amp;rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.&lt;br /&gt;&lt;br /&gt;Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 8889,
	&#039;title&#039; =&gt; &#039;UN hails studies showing antiretroviral drugs can prevent HIV infection&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;p&gt;
-The United Nations 
&lt;/p&gt;
&lt;p&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;div align=&quot;justify&quot;&gt;
The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.&lt;br /&gt;
&lt;br /&gt;
The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&amp;rdquo; said Michel Sidib&amp;eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &amp;ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&amp;rdquo; he added.&lt;br /&gt;
&lt;br /&gt;
One of the studies, conducted by the University of Washington&amp;rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &amp;ndash; in which one person had HIV infection and the other did not &amp;ndash; in Kenya and Uganda.&lt;br /&gt;
&lt;br /&gt;
The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.&lt;br /&gt;
&lt;br /&gt;
The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.&lt;br /&gt;
&lt;br /&gt;
The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.&lt;br /&gt;
&lt;br /&gt;
In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.&lt;br /&gt;
&lt;br /&gt;
&amp;ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&amp;rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &amp;ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&amp;rdquo; she said.&lt;br /&gt;
&lt;br /&gt;
UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.&lt;br /&gt;
&lt;br /&gt;
It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.&lt;br /&gt;
&lt;br /&gt;
UNAIDS and WHO recommended that individuals and couples make &amp;ldquo;evidence-informed decisions&amp;rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.&lt;br /&gt;
&lt;br /&gt;
Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The United Nations, 13 July, 2011, http://www.un.org/apps/news/story.asp?NewsID=39023&amp;Cr=HIV/AIDS&amp;Cr1=&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 8991,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 8889
$metaTitle = &#039;LATEST NEWS UPDATES | UN hails studies showing antiretroviral drugs can prevent HIV infection&#039;
$metaKeywords = &#039;Health&#039;
$metaDesc = &#039;
-The United Nations 


&amp;nbsp;


The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected...&#039;
$disp = &#039;&lt;p&gt;-The United Nations &lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;div align=&quot;justify&quot;&gt;The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.&lt;br /&gt;&lt;br /&gt;The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&amp;rdquo; said Michel Sidib&amp;eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &amp;ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&amp;rdquo; he added.&lt;br /&gt;&lt;br /&gt;One of the studies, conducted by the University of Washington&amp;rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &amp;ndash; in which one person had HIV infection and the other did not &amp;ndash; in Kenya and Uganda.&lt;br /&gt;&lt;br /&gt;The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.&lt;br /&gt;&lt;br /&gt;The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.&lt;br /&gt;&lt;br /&gt;The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.&lt;br /&gt;&lt;br /&gt;In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.&lt;br /&gt;&lt;br /&gt;&amp;ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&amp;rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &amp;ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&amp;rdquo; she said.&lt;br /&gt;&lt;br /&gt;UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.&lt;br /&gt;&lt;br /&gt;It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.&lt;br /&gt;&lt;br /&gt;UNAIDS and WHO recommended that individuals and couples make &amp;ldquo;evidence-informed decisions&amp;rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.&lt;br /&gt;&lt;br /&gt;Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | UN hails studies showing antiretroviral drugs can prevent HIV infection | Im4change.org</title>
    <meta name="description" content="
-The United Nations 


&nbsp;


The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>UN hails studies showing antiretroviral drugs can prevent HIV infection</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <p>-The United Nations </p><p>&nbsp;</p><div align="justify">The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.<br /><br />The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.<br /><br />&ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&rdquo; said Michel Sidib&eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&rdquo; he added.<br /><br />One of the studies, conducted by the University of Washington&rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &ndash; in which one person had HIV infection and the other did not &ndash; in Kenya and Uganda.<br /><br />The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.<br /><br />The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.<br /><br />The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.<br /><br />In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.<br /><br />&ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&rdquo; she said.<br /><br />UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.<br /><br />It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.<br /><br />UNAIDS and WHO recommended that individuals and couples make &ldquo;evidence-informed decisions&rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.<br /><br />Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 8889,
		'title' => 'UN hails studies showing antiretroviral drugs can prevent HIV infection',
		'subheading' => '',
		'description' => '<p>
-The United Nations 
</p>
<p>
&nbsp;
</p>
<div align="justify">
The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.<br />
<br />
The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.<br />
<br />
&ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&rdquo; said Michel Sidib&eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&rdquo; he added.<br />
<br />
One of the studies, conducted by the University of Washington&rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &ndash; in which one person had HIV infection and the other did not &ndash; in Kenya and Uganda.<br />
<br />
The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.<br />
<br />
The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.<br />
<br />
The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.<br />
<br />
In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.<br />
<br />
&ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&rdquo; she said.<br />
<br />
UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.<br />
<br />
It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.<br />
<br />
UNAIDS and WHO recommended that individuals and couples make &ldquo;evidence-informed decisions&rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.<br />
<br />
Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. <br />
</div>',
		'credit_writer' => 'The United Nations, 13 July, 2011, http://www.un.org/apps/news/story.asp?NewsID=39023&Cr=HIV/AIDS&Cr1=',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 8991,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 8889,
	'metaTitle' => 'LATEST NEWS UPDATES | UN hails studies showing antiretroviral drugs can prevent HIV infection',
	'metaKeywords' => 'Health',
	'metaDesc' => '
-The United Nations 


&nbsp;


The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected...',
	'disp' => '<p>-The United Nations </p><p>&nbsp;</p><div align="justify">The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.<br /><br />The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.<br /><br />&ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&rdquo; said Michel Sidib&eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&rdquo; he added.<br /><br />One of the studies, conducted by the University of Washington&rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &ndash; in which one person had HIV infection and the other did not &ndash; in Kenya and Uganda.<br /><br />The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.<br /><br />The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.<br /><br />The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.<br /><br />In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.<br /><br />&ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&rdquo; she said.<br /><br />UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.<br /><br />It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.<br /><br />UNAIDS and WHO recommended that individuals and couples make &ldquo;evidence-informed decisions&rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.<br /><br />Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. <br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 8889,
	'title' => 'UN hails studies showing antiretroviral drugs can prevent HIV infection',
	'subheading' => '',
	'description' => '<p>
-The United Nations 
</p>
<p>
&nbsp;
</p>
<div align="justify">
The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.<br />
<br />
The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.<br />
<br />
&ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&rdquo; said Michel Sidib&eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&rdquo; he added.<br />
<br />
One of the studies, conducted by the University of Washington&rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &ndash; in which one person had HIV infection and the other did not &ndash; in Kenya and Uganda.<br />
<br />
The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.<br />
<br />
The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.<br />
<br />
The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.<br />
<br />
In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.<br />
<br />
&ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&rdquo; she said.<br />
<br />
UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.<br />
<br />
It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.<br />
<br />
UNAIDS and WHO recommended that individuals and couples make &ldquo;evidence-informed decisions&rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.<br />
<br />
Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. <br />
</div>',
	'credit_writer' => 'The United Nations, 13 July, 2011, http://www.un.org/apps/news/story.asp?NewsID=39023&Cr=HIV/AIDS&Cr1=',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'un-hails-studies-showing-antiretroviral-drugs-can-prevent-hiv-infection-8991',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 8991,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 8889
$metaTitle = 'LATEST NEWS UPDATES | UN hails studies showing antiretroviral drugs can prevent HIV infection'
$metaKeywords = 'Health'
$metaDesc = '
-The United Nations 


&nbsp;


The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected...'
$disp = '<p>-The United Nations </p><p>&nbsp;</p><div align="justify">The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS.<br /><br />The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men.<br /><br />&ldquo;This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,&rdquo; said Michel Sidib&eacute;, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). &ldquo;These studies could help us to reach the tipping point in the HIV epidemic,&rdquo; he added.<br /><br />One of the studies, conducted by the University of Washington&rsquo;s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples &ndash; in which one person had HIV infection and the other did not &ndash; in Kenya and Uganda.<br /><br />The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study.<br /><br />The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women.<br /><br />The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet.<br /><br />In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet.<br /><br />&ldquo;Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,&rdquo; Margaret Chan, the Director-General of the World Health Organization (WHO), said. &ldquo;WHO will be working with countries to use the new findings to protect more men and women from HIV infection,&rdquo; she said.<br /><br />UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention.<br /><br />It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said.<br /><br />UNAIDS and WHO recommended that individuals and couples make &ldquo;evidence-informed decisions&rdquo; on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection.<br /><br />Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added. <br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

UN hails studies showing antiretroviral drugs can prevent HIV infection

-The United Nations   The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS. The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive pre-exposure prophylaxis (PrEP) medicines, can prevent heterosexual transmission of HIV from men to women and from women to men. “This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,” said Michel Sidibé, the Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS). “These studies could help us to reach the tipping point in the HIV epidemic,” he added. One of the studies, conducted by the University of Washington’s International Clinical Research Center and dubbed Partners PrEP, followed 4,758 sero-discordant couples – in which one person had HIV infection and the other did not – in Kenya and Uganda. The uninfected partner took a once-daily tenofovir tablet or a tenofovir/emtricitabine tablet or a placebo pill. There were 62 per cent fewer HIV infections in the group receiving tenofovir and 73 per cent fewer HIV infections in the group that took tenofovir /emtricitabine than in the group receiving the placebo, according to the study. The second study, termed TDF2 trial, conducted by the United States Centers for Disease Control, followed 1,200 men and women in Botswana who received either a once-daily tenofovir/emtricitabine tablet or a placebo pill. The antiretroviral tablet reduced the risk of acquiring HIV infection by roughly 63 per cent overall in the study population of uninfected heterosexual men and women. The drugs used are available in their generic forms in many countries at prices as low as $0.25 per tablet. In November last year, a trial among men who have sex with men in six countries reported a 44 per cent reduction in HIV transmission among those who took a daily tenofovir/emtricitabine tablet. “Effective new HIV prevention tools are urgently needed, and these studies could have enormous impact in preventing heterosexual transmission,” Margaret Chan, the Director-General of the World Health Organization (WHO), said. “WHO will be working with countries to use the new findings to protect more men and women from HIV infection,” she said. UNAIDS and WHO have already been working with countries in sub-Saharan Africa, Latin America and Asia to explore the potential role of pre-exposure prophylaxis in HIV prevention. It is currently estimated that only about half of the 33 million people living with HIV know their status. An increase in testing for HIV would have a significant impact on the AIDS response, particularly if more people gain access to new HIV prevention technologies in light of the new findings, the two UN agencies said. UNAIDS and WHO recommended that individuals and couples make “evidence-informed decisions” on which combination of HIV prevention options is best for them, stressing that the no single method is fully protective against HIV infection. Antiretroviral drugs for prevention need to be combined with other HIV prevention options, including correct and consistent use of male and female condoms, waiting longer before having sex for the first time, having fewer partners, medical male circumcision and avoiding penetrative sex, they added.